BRIAN MAUSSER: Open Payments
NPI 1396518429 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 71 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $942 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $333 |
| Vanda Pharmaceuticals Inc. | 14 | $214 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $169 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Supernus Pharmaceuticals, Inc. | 4 | $65 |
| Alkermes, Inc. | 3 | $59 |
| Lundbeck LLC | 3 | $56 |
| Corium, LLC | 4 | $45 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Neos Therapeutics, LP | 2 | $40 |
Products named: REXULTI, CAPLYTA, HETLIOZ, FANAPT, Qelbree, Azstarys, Auvelity, Adzenys XR-ODT.
Industry payments across OH — which companies pay providers there.
